Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 1/14/25 → 1/14/26 |
Funding
- IQVIA RDS Incorporated: $28,832.00
ONO-2020-02: A Phase II, 26-week, double-blind, placebo-controlled study to assess the safety, tolerability, pharmacokinetics, and efficacy of ONO-2020 in patients with mild to moderate Alzheimer#s Disease
- Jicha, Gregory (PI)